SightfileU.S. market data from official filings

Companies › GRAL

GRAIL INC (GRAL)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001699031 · EDGAR filings · Updated 2026-07-28

GRAIL INC (GRAL) has reported institutional ownership of 85.7%, with 362 institutional managers holding positions valued at $1.82B per the latest 13F reporting period. SEC filings include an active material impairment disclosure (8-K Item 2.06).

Institutional ownership
85.7%
Institutional managers
362
Reported 13F value
$1.82B
Insider activity
60 trans.
−$123.7M net selling
Data flags
1 active
from SEC filings

Filings this week (1)

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, GRAIL INC has 362 institutional holders and institutional ownership of 85.7%.

Insider activity

Insiders reported 60 transactions (0 buys, 42 sells) across 9 reporting insiders, with a net reported value of −$123.7M.

Data flags from SEC filings

Active material impairment disclosure (8-K Item 2.06), most recently filed 2024-06-27 (recurring since 2024-06-27) — source filing. The authoritative details are those stated in the filing itself.

Related companies

SURGERY PARTNERS INC (SGRY) · RELAY THERAPEUTICS INC (RLAY) · TAKEDA PHARMACEUTICAL CO LTD (TAK) · SIONNA THERAPEUTICS INC (SION) · NURIX THERAPEUTICS INC (NRIX) · ADDUS HOMECARE CORP COM (ADUS)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-28.